Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to letter regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial".
Ibanez B, Macaya C, Sánchez-Brunete V, Pizarro G, Fernández-Friera L, Mateos A, Fernández-Ortiz A, García-Ruiz JM, García-Álvarez A, Iñiguez A, Jiménez-Borreguero J, López-Romero P, Fernández-Jiménez R, Goicolea J, Ruiz-Mateos B, Bastante T, Arias M, Iglesias-Vázquez JA, Rodriguez MD, Escalera N, Acebal C, Cabrera JA, Valenciano J, de Prado AP, Fernández-Campos MJ, Casado I, García-Rubira JC, García-Prieto J, Sanz-Rosa D, Cuellas C, Hernández-Antolín R, Albarrán A, Fernández-Vázquez F, de la Torre-Hernández JM, Pocock S, Sanz G, Fuster V. Ibanez B, et al. Among authors: de prado ap, de la torre hernandez jm. Circulation. 2014 Jul 15;130(3):e19-20. doi: 10.1161/CIRCULATIONAHA.114.009352. Circulation. 2014. PMID: 25024129 No abstract available.
Preclinical evaluation of coronary stents: focus on safety issues.
de Prado AP, Perez-Martinez C, Cuellas C, Gonzalo-Orden JM, Diego A, Regueiro M, Martinez-Fernandez B, Altonaga JR, Marin Francisco JG, Fernandez-Vazquez F. de Prado AP, et al. Curr Vasc Pharmacol. 2013 Jan;11(1):74-99. Curr Vasc Pharmacol. 2013. PMID: 22724463 Review.
[No title available]
Diego-Nieto A, Cuellas-Ramón C, de Prado AP, Fernández-Vázquez F. Diego-Nieto A, et al. Among authors: de prado ap. Rev Esp Cardiol. 2008 Apr;61(4):434-5. doi: 10.1157/13117741. Epub 2008 Dec 24. Rev Esp Cardiol. 2008. PMID: 23063358 Free article. English, Spanish. No abstract available.
Third CoreValve™ insertion for treatment of a severe paravalvular leak after a failed valve-in-valve procedure.
Estévez-Loureiro R, Cuellas C, Gualis J, de Prado AP, Castaño M, Soria C, Alonso D, Garrote C, Rodríguez MÁ, Fernández-Vázquez F. Estévez-Loureiro R, et al. Among authors: de prado ap. Int J Cardiol Heart Vasc. 2015 Feb 26;7:58-60. doi: 10.1016/j.ijcha.2015.02.006. eCollection 2015 Jun 1. Int J Cardiol Heart Vasc. 2015. PMID: 28785646 Free PMC article.
No Differences in Levels of Circulating Progenitor Endothelial Cells or Circulating Endothelial Cells Among Patients Treated With Ticagrelor Compared With Clopidogrel During Non- ST -Segment-Elevation Myocardial Infarction.
Diego-Nieto A, Vidriales MB, Alonso-Orcajo N, Moreno-Samos JC, Martin-Herrero F, Carbonell R, Cid B, Cruz-Gonzalez I, Martin-Moreiras JC, Cuellas C, Pascual C, Lopez-Benito M, Sanchez PL, Fernandez-Vazquez F, de Prado AP. Diego-Nieto A, et al. Among authors: de prado ap. J Am Heart Assoc. 2018 Oct 2;7(19):e009444. doi: 10.1161/JAHA.118.009444. J Am Heart Assoc. 2018. PMID: 30371302 Free PMC article. Clinical Trial.
Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial.
Amat-Santos IJ, Sánchez-Luna JP, Abu-Assi E, Melendo-Viu M, Cruz-Gonzalez I, Nombela-Franco L, Muñoz-Garcí AJ, Blas SG, de la Torre Hernandez JM, Romaguera R, Sánchez-Recalde Á, Diez-Gil JL, Lopez-Otero D, Gheorge L, Ibáñez B, Iñiguez-Romo A, Raposeiras-Roubín S; Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) Investigators. Amat-Santos IJ, et al. Eur J Heart Fail. 2022 Mar;24(3):581-588. doi: 10.1002/ejhf.2370. Epub 2021 Nov 9. Eur J Heart Fail. 2022. PMID: 34693613 Free article. Clinical Trial.
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial.
Romaguera R, Salinas P, Gomez-Lara J, Brugaletta S, Gómez-Menchero A, Romero MA, García-Blas S, Ocaranza R, Bordes P, Kockar MJ, Salvatella N, Jiménez-Díaz VA, Alameda M, Trillo R, Lee DH, Martín P, López-Benito M, Freites A, Pascual-Tejerina V, Hernández-Hernández F, Blanco BGD, Mohandes M, Bosa F, Pinar E, Roura G, Comin-Colet J, Fernández-Ortiz A, Macaya C, Rossello X, Sabate M, Pocock SJ, Gómez-Hospital JA; SUGAR trial investigators. Romaguera R, et al. Eur Heart J. 2022 Mar 31;43(13):1320-1330. doi: 10.1093/eurheartj/ehab790. Eur Heart J. 2022. PMID: 34735004 Free PMC article. Clinical Trial.
Instantaneous wave-free ratio for guiding treatment of nonculprit lesions in patients with acute coronary syndrome: A retrospective study.
Hidalgo F, Gonzalez-Manzanares R, Ojeda S, Benito-González T, Gutiérrez-Barrios A, De la Torre Hernández JM, Minguito-Carazo C, Izaga-Torralba E, Cabrera-Rubio I, Flores-Vergara G, de Lezo JS, Romero-Moreno M, de Prado AP, Pan M. Hidalgo F, et al. Among authors: de prado ap. Catheter Cardiovasc Interv. 2022 Feb;99(2):489-496. doi: 10.1002/ccd.30025. Epub 2021 Dec 4. Catheter Cardiovasc Interv. 2022. PMID: 34862839
25 results